Biotricity, Inc. (BTCY): רווח למניה בשנים עשר החודשים האחרונים
Biotricity, Inc. (BTCY) is fighting for the attention of insurers amidst fierce competition from tech giants. Meanwhile, the software subscription model and B2B device deliveries create powerful operating leverage. Biotricity, Inc. (BTCY) focuses on preventive cardiology, expanding its reach within the wearable devices market. The trend in rolling net income per share clearly demonstrates these processes, and the value has stabilized at -1.65.
פילוחי מדדים ואנליטיקה של חברת Biotricity, Inc (BTCY)
Net income per share (TTM) measures the specific return on equity by distributing the total financial result across all issued securities. This metric serves as a tool for portfolio stress testing during periods of market volatility. By analyzing the annual net income per share trend, an investor assesses the actual efficiency of the business. For Biotricity, Inc. (BTCY), this indicator reflects the balance between growing demand for telemedicine and logistical disruptions in chip supplies. The indicator's dynamics confirm the company's resilience to external geopolitical shocks.
